According to the research report titled ‘Global Bioimpedance Device Market Size study, by Product (Multi-Frequency Analysers, Single-Frequency Analysers, Dual-Frequency Analysers), by Modality (Wired Bioimpedance Analyzers, Wireless Bioimpedance Analyzers), by Application (Whole Body Measurement, Segmental Body Measurement), by End-Users (Fitness clubs & Wellness Centres, Home Users, Hospitals, Other End-Users) and Regional Forecasts 2022-2028’, available with MarketStudyReport, global bioimpedance device market accounted for USD 389.29 million in 2021 and is projected to reach USD 768.32 million by the year 2028, witnessing over 10.2% CAGR during the analysis timeframe.

The surging health-conscious population and rising prevalence of chronic and lifestyle diseases are some of the major factors driving the expansion of global bioimpedance device market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5110062/  

Apart from this, increasing R&D activities, surging disposable income, and subsequent technological breakthroughs will add traction to the overall market size in the subsequent years.

For those unaware, a bioimpedance device is a lifting device that can be used to lift any large object. The device is flexible, robust, and safe, making it possible for one person to use and carry from one place to another, thus contributing towards its popularity across the globe.

However, fluctuating accuracy associated with the product is predicted to obstruct the overall market expansion in the forthcoming years.

Based on the product type, the market is divided into dual-frequency analyzers, single-frequency analyzers, and multi-frequency analyzers. By mortality, the industry is bifurcated into wireless bio impedance analyzers and wired bioimpedance analyzers.

In terms of the application spectrum, the market is fragmented into segmental body measurement and whole-body measurement. With respect to the end-user terrain, the industry is segmented into hospitals, home users, fitness clubs & wellness centers, and others.

The geographical analysis of this business sphere extends to North America, Europe, Asia-Pacific, as well as Latin America with key emphasis on the U.S., Canada, U.K., Germany, France, Italy, Spain, India, China, Japan, South Korea, Australia, Brazil, and Mexico, and the rest of the world.

The report claims that North America bioimpedance device market is estimated to witness substantial growth over the forecast period owing to growing government-funded initiatives to overcome life-threatening diseases like blood pressure and obesity.

Whereas Asia Pacific market is also anticipated to exhibit significant growth during 2022-2028, on account of the surging number of patients with lifestyle-related diseases.

Bodystat Ltd., Fook Tin Group Holdings Ltd., Charder Electronic Co. Ltd., SELVAS Healthcare, Evolt 360, seca GmbH & Co. KG., RJL Systems, InBody, Tanita Corporation, and Omron Corporation are the prominent companies in global bioimpedance device industry landscape.